Pharmacokinetic Challenges in Drug Discovery
Seiten
2002
Springer Berlin (Verlag)
978-3-540-42585-4 (ISBN)
Springer Berlin (Verlag)
978-3-540-42585-4 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
- 37
Despite increased spending on research and development, the number of new medicines marketed successfully continues to decline. The pharmaceutical industry is therefore focussing on ways to reduce attrition by addressing frequent reasons for clinical drug failures very early in the drug discovery process. One of the biggest challenges is the pharmacokinetic (PK) optimization of drug candidates tailored and predicted to have appropriate absorption, distribution, metabolism and excretion (ADME) characteristics in humans. This book describes how traditional pharmacokinetic approaches and methods are being re-invented to meet specific needs dictated by the dynamics of the drug discovery process. The book gives an overview of state-of-the-art tools, and their use in the decision-making process is discussed by a number of scientists from leading pharmaceutical companies.
Zusatzinfo | 83 figs., 18 tabs. |
---|---|
Sprache | englisch |
Gewicht | 540 g |
Einbandart | gebunden |
Themenwelt | Medizin / Pharmazie ► Pharmazie |
Schlagworte | HC/Medizin/Pharmazie |
ISBN-10 | 3-540-42585-3 / 3540425853 |
ISBN-13 | 978-3-540-42585-4 / 9783540425854 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Pharmaceuticals, Diagnostics, Medical Devices
Buch | Hardcover (2023)
Wiley-VCH (Verlag)
CHF 109,95
lernfeldorientiert und fächerübergreifend 2. Schuljahr
Buch (2024)
Deutscher Apotheker Verlag
CHF 41,70